Abstract
Trisomy 21 is the most prevalent numeric or structural chromosomal aberration. Nowadays, prenatal tests for screening and diagnosing trisomy 21, as well as some other chromosomal aberrations, exist. The existence of prenatal tests allows, but at the same time forces, pregnant women to make decisions and choices. Ethically delicate questions arise such as the value of unborn life, the value of a life of a child with a mental handicap, and the consideration about pros and cons regarding the impact on the parents’ life. The complexity of the situation affords comprehensive information and counseling by health professionals previous to any prenatal testing, but especially when a chromosomal aberration or major fetal malformation is suspected or diagnosed. The decision whether to terminate pregnancy or not is very much dependent on the individual evaluation of the couples concerned. A nonjudgmental and nondirective approach especially during the shared decision-making process is of utmost importance. Thereafter, health professionals are confronted with the challenging task to provide support and meet the specific needs of those couples that decide to terminate and those that carry out pregnancy. This support should include not only follow-up visits after delivery but also special care during a next pregnancy, which is generally experienced as highly stressful.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Patterson D. Molecular genetic analysis of down syndrome. Hum Genet. 2009;126(1):195–214.
Weijerman ME, de Winter JP. Clinical practice. The care of children with down syndrome. Eur J Pediatr. 2010;169(12):1445–52.
Lammens M, ten Donkelaar HJ, van Vugt J, van Noort G, Willemsen M, Hamel B. Causes of congenital malformations. Clinical neuroembryology. Berlin/Heidelberg: Springer; 2006. p. 97–143.
Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. [Review]. 2003;3:CD003252.
Scott F, Peters H, Boogert T, Robertson R, Anderson J, McLennan A, et al. The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice. Aust N Z J Obstet Gynaecol. [Comparative Study]. 2002;42(1):55–8.
Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, et al. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol. 2001;18(6):645–8.
Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31(6):618–24.
Tercanli S, Holzgreve W, Batukan C, Gerber A, Ermis H, Miny P. Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland. Ultraschall Med. 2002;23(1):22–6.
Wong BC, Lo YM. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev Mol Diagn. [Research Support, Non-U.S. Gov’t Review]. 2003;3(6):785–97.
Benn P, Cuckle H, Pergament E. Non-invasive prenatal diagnosis for down syndrome: the paradigm will shift, but slowly. Ultrasound Obstet Gynecol. 2012;39(2):127–30.
Chitty LS. Ultrasound screening for fetal abnormalities. Prenat Diagn. 1995;15(13):1241–57.
Beauchamp TL, Childress JF. Principles biomedical ethics. 5th ed. Oxford: Oxford University Press; 2001.
WHO. Congenital anomalies. 2014; Available from: http://www.who.int/mediacentre/factsheets/fs370/en/.
Gotzmann L, Romann C, Schonholzer SM, Klaghofer R, Zimmermann R, Buddeberg C. Communication competence in ultrasound examination in pregnancy. Gynakol Geburtshilfliche Rundsch. 2001;41(4):215–22.
Miller WR, Rollnick S. Motivational interviewing: preparing people for change. New York: Guilford Press; 2002.
Rogers C, Farson R. Active listening. In: Kolb D, Rubin I, MacIntyre J, editors. Organizational psychology. 3rd ed. Englewood: Prentice Hall; 1979.
Tschudin S, Holzgreve W, Conde N, Alder J, Bitzer J, Tercanli S. Pregnant women’s assessment and level of knowledge of prenatal counseling. Ultraschall Med. 2009;30(2):157–62.
Tschudin S, Huang D, Mor-Gultekin H, Alder J, Bitzer J, Tercanli S. Prenatal counseling–implications of the cultural background of pregnant women on information processing, emotional response and acceptance. Ultraschall Med. [Comparative Study]. 2011;32(Suppl 2):E100–107.
Hughes P, Riches S. Psychological aspects of perinatal loss. Curr Opin Obstet Gynecol. 2003;15(2):107–11.
Kersting A, Wagner B. Complicated grief after perinatal loss. Dialogues Clin Neurosci. 2012;14(2):187–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tschudin, S., Verhaak, C. (2017). A Woman with a Positive Prenatal Test on Trisomy 21: Counseling in Prenatal Diagnosis. In: Paarlberg, K., van de Wiel, H. (eds) Bio-Psycho-Social Obstetrics and Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-40404-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-40404-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40402-8
Online ISBN: 978-3-319-40404-2
eBook Packages: MedicineMedicine (R0)